As the biotech industry continues to push the boundaries of innovation, Alcon’s recent FDA approval of the acoltremon ophthalmic solution 0.003% has marked a crucial turning point in the treatment of Dry Eye Disease (DED). This serves as more than just another regulatory nod; it introduces a first-of-its-kind TRPM8 receptor agonist that pioneers a novel […]
Tag: Alcon
Advancing Genome Editing Research with Koffas’ Award
The Howard P. Isermann Department of Chemical and Biological Engineering, in collaboration with the School of Engineering at Rensselaer Polytechnic Institute (RPI), is thrilled to announce that Mattheos Koffas, Ph.D., has been selected as the recipient of the inaugural Feltham ReEquip Award. This award was created to propel groundbreaking scientific research and foster educational innovation […]
